CN103313985B — 嘧啶并[6,1-a]异喹啉-4-酮化合物的结晶型
Assigned to Verona Pharma Ltd · Expires 2016-03-02 · 10y expired
What this patent protects
本发明是关于N-{2-[(2E)-2-(三甲苯基亚氨基)-9,10-二甲氧基-4-侧氧基-6,7-二氢-2H-嘧啶并[6,1-a]-异喹啉-3(4H)-基]乙基}脲的多晶型体,其是呈由多于99重量%的N-{2-[(2E)-2-(三甲苯基亚氨基)-9,10-二甲氧基-4-侧氧基-6,7-二氢-2H-嘧啶并[6,1-a]-异喹啉-3(4H)-基]乙基}脲所组成的结晶固体型,该多晶型体型中至少95%为N-{2-[(2E)-2-(三甲苯基亚氨基)-9,10-二甲氧基-4-侧氧基-6,7-二氢-2H-嘧啶并[6,1-a]-异喹啉-3(4H)-基]乙基}脲的热动学安…
USPTO Abstract
本发明是关于N-{2-[(2E)-2-(三甲苯基亚氨基)-9,10-二甲氧基-4-侧氧基-6,7-二氢-2H-嘧啶并[6,1-a]-异喹啉-3(4H)-基]乙基}脲的多晶型体,其是呈由多于99重量%的N-{2-[(2E)-2-(三甲苯基亚氨基)-9,10-二甲氧基-4-侧氧基-6,7-二氢-2H-嘧啶并[6,1-a]-异喹啉-3(4H)-基]乙基}脲所组成的结晶固体型,该多晶型体型中至少95%为N-{2-[(2E)-2-(三甲苯基亚氨基)-9,10-二甲氧基-4-侧氧基-6,7-二氢-2H-嘧啶并[6,1-a]-异喹啉-3(4H)-基]乙基}脲的热动学安定的多晶型体(I),其中,该多晶型体是通过单晶X-射线结构分析与X-射线粉末衍射图样测定。
Drugs covered by this patent
- Ohtuvayre (ENSIFENTRINE) · Verona Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.